Enhabit, Inc. (NYSE:EHAB) Receives $13.31 Consensus PT from Brokerages

Enhabit, Inc. (NYSE:EHAB) has been given a consensus recommendation of “Hold” by the nine ratings firms that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, six have given a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $13.5714.

Several brokerages have recently issued reports on EHAB. UBS Group restated a “neutral” rating and issued a $13.80 target price (up from $12.00) on shares of Enhabit in a report on Tuesday, February 24th. Oppenheimer lowered shares of Enhabit from an “outperform” rating to a “market perform” rating in a report on Monday, February 23rd. Leerink Partners boosted their price objective on shares of Enhabit from $9.50 to $13.80 and gave the company a “market perform” rating in a research report on Monday, February 23rd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Enhabit in a research note on Monday, December 29th. Finally, Jefferies Financial Group lowered shares of Enhabit from a “buy” rating to a “hold” rating and increased their target price for the stock from $12.50 to $13.80 in a report on Monday, February 23rd.

Institutional Investors Weigh In On Enhabit

Several institutional investors and hedge funds have recently bought and sold shares of the business. 8 Knots Management LLC boosted its position in shares of Enhabit by 20.5% during the fourth quarter. 8 Knots Management LLC now owns 5,084,714 shares of the company’s stock valued at $46,881,000 after purchasing an additional 865,868 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Enhabit by 8.2% during the 3rd quarter. Vanguard Group Inc. now owns 3,393,069 shares of the company’s stock valued at $27,178,000 after buying an additional 256,559 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Enhabit by 1.0% during the 4th quarter. Geode Capital Management LLC now owns 1,187,434 shares of the company’s stock valued at $10,951,000 after buying an additional 11,583 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of Enhabit by 30.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 866,539 shares of the company’s stock worth $7,989,000 after buying an additional 201,269 shares during the period. Finally, Hillsdale Investment Management Inc. bought a new position in shares of Enhabit in the 4th quarter worth about $7,567,000.

Enhabit Stock Up 0.1%

Shares of NYSE:EHAB opened at $13.62 on Wednesday. The stock has a market capitalization of $689.31 million, a P/E ratio of -151.33 and a beta of 1.56. The stock’s 50-day moving average price is $11.13 and its 200-day moving average price is $9.37. The company has a current ratio of 1.63, a quick ratio of 1.58 and a debt-to-equity ratio of 0.76. Enhabit has a 12-month low of $6.47 and a 12-month high of $13.64.

Enhabit (NYSE:EHAB) last released its earnings results on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.14. Enhabit had a positive return on equity of 4.71% and a negative net margin of 0.43%.The company had revenue of $270.40 million during the quarter, compared to analyst estimates of $270.56 million. On average, equities analysts anticipate that Enhabit will post 0.22 earnings per share for the current year.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.